Methods for reducing the risk of an adverse teriflunomide and rosuvastatin interaction in multiple sclerosis patients | Patent Number 09186346

US 09186346 B2
Application Number14172082
Publication NumberUS 20140256758 A1
Pendency1 year, 9 months, 16 days
Filled DateFeb 4, 2014
Priority DateMar 12, 2013
Publication DateSep 11, 2014
Expiration DateMar 11, 2033
Inventor/ApplicantsFrancoise Menguy-Vacheron
Pierre-Francois Clot
Dietmar Weitz
Sandrine TURPAULT
Sandrine Turpault
Pierre-Francois CLOT
Francoise MENGUY-VACHERON
Dietmar WEITZ
ExaminesTRAN, MY CHAU T
Art Unit1629
Technology Center1600
Assignments
Sanofi
Current
Sanofi
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.